Stoke Therapeutics (STOK) FCF Margin Growth (1y) (2023 - 2026)
Powered by 
Analysis
Stoke Therapeutics (STOK) FCF Margin Growth (1y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 811.00 |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 19,111.00 |
| 10 | Stoke Therapeutics | 1.96 Bn | 1.66 Bn | - | -44,289.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44,289.00 |
| Mar 31, 2026 | -106,129.00 |
| Dec 31, 2025 | -208,598.00 |
| Sep 30, 2025 | 15,692.00 |
| Jun 30, 2025 | 17,761.00 |
| Mar 31, 2025 | 66,601.00 |
| Dec 31, 2024 | 64,236.00 |
| Sep 30, 2024 | 8,964.00 |
| Jun 30, 2024 | 53,446.00 |
| Mar 31, 2024 | -15,787.00 |
| Dec 31, 2023 | -4,799.00 |
| Sep 30, 2023 | 29,572.00 |
| Jun 30, 2023 | -25,930.00 |
| Mar 31, 2023 | -148,010.00 |